Gillespie D D, Manier D H, Sanders-Bush E, Sulser F
Department of Pharmacology, Vanderbilt University School of Medicine, Tennessee.
J Pharmacol Exp Ther. 1988 Jan;244(1):154-9.
The present studies were undertaken to characterize further the role of serotonin (5-HT) in the regulation of the norepinephrine (NE) beta adrenoceptor coupled adenylate cyclase system in the rat cortex. Although 5-HT in vitro did not influence maximum binding and Kd values of [3H]dihydroalprenolol binding or the IC50 value for isoproterenol as estimated from competition binding curves in cortical tissue from control animals, 5-HT abolished the increase in beta adrenoceptor number and the marked elevation of the IC50 value for isoproterenol in cortical membrane preparations after selective lesions with 5,7-dihydroxytryptamine (5,7-DHT). Nonlinear regression analysis of competition binding curves revealed that the increase in the maximum binding of beta adrenoceptors after 5,7-DHT is due exclusively to an increase in beta adrenoceptors in the agonist low affinity conformation and that it is this receptor population that is reduced by nanomolar concentrations of 5-HT. The increase in the density of beta adrenoceptors in the low affinity conformation occurred approximately 11 days after the lesions and remained elevated throughout the experimental period of 28 days. Ritanserin in a dose that virtually abolished 5-HT2 receptor binding in cortex did not mimic the effect of 5,7-DHT.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究旨在进一步阐明血清素(5-羟色胺,5-HT)在大鼠皮层中去甲肾上腺素(NE)β肾上腺素能受体偶联腺苷酸环化酶系统调节中的作用。虽然体外5-HT并不影响[3H]二氢阿普洛尔结合的最大结合量和Kd值,也不影响根据对照动物皮层组织竞争结合曲线估算的异丙肾上腺素IC50值,但在用5,7-二羟色胺(5,7-DHT)进行选择性损伤后,5-HT消除了皮层膜制剂中β肾上腺素能受体数量的增加以及异丙肾上腺素IC50值的显著升高。竞争结合曲线的非线性回归分析表明,5,7-DHT后β肾上腺素能受体最大结合量的增加完全是由于激动剂低亲和力构象的β肾上腺素能受体增加,而正是这种受体群体被纳摩尔浓度的5-HT所减少。低亲和力构象的β肾上腺素能受体密度增加发生在损伤后约11天,并在整个28天的实验期内持续升高。在皮层中几乎消除5-HT2受体结合的剂量的利坦色林并不能模拟5,7-DHT的作用。(摘要截短于250字)